# Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment

> **NCT00984815** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 86 (actual)

## Conditions studied

- Osteoarthritis
- Rheumatoid Arthritis
- Chronic Low Back Pain
- Chronic Regional Pain Syndrome
- Chronic Soft Tissue Pain

## Interventions

- **DRUG:** HZT-501

## Key facts

- **NCT ID:** NCT00984815
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00984815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00984815, "Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00984815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*